ArticleInternational journal of biological sciences2018

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction.

Bin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.